跳至主要内容
临床试验/NCT06190379
NCT06190379已完成不适用

Aromatherapy for Upper Respiratory Health: A Randomized, Placebo Controlled, Triple-Blind Clinical Trial

Nutraceuticals Research Institute2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2022年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
45
试验地点
2
主要终点
severity of respiratory symptoms

研究概览

简要总结

The purpose of this study is to confirm and quantify the effects of aromatherapy on respiratory health.

详细描述

Participants will inhale the scent from an aroma stick every waking hour for the entire duration of a period of respiratory symptoms or 14 days, whichever is shorter. As it is a randomized, placebo-controlled study, some participants will inhale the scent from an aroma stick containing active essential oils while other participants will inhale from an aroma stick containing no essential oils.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Provision of signed and dated informed consent form
  • Stated willingness and demonstrated ability to comply with all study procedures and availability for the duration of the study
  • Gender expression: female
  • Aged 20-65
  • In good general health
  • Exhibiting routine upper respiratory symptoms such as: sneezing, coughing, running nose, headache, general fatigue, or dry or sore throat, etc.
  • Ability to utilize the inhaler and be willing to adhere to the regimen

排除标准

  • Current use of bronchodilators or asthma medications
  • Presence of asthma diagnosis or other severe breathing disorder
  • Pregnant or trying to conceive
  • Known allergic reactions to components of the inhaler, specifically plants in the following families: rutaceae, pinaceae, labiatae, and myrtaceae.
  • Treatment with another investigational drug or other intervention within 30 days
  • Current smoker
  • COVID-19 diagnosis

结局指标

主要结局

severity of respiratory symptoms

时间窗: 14 days

Respiratory symptoms are measured using the Franklin Immune Scale, Respiratory Subdomain, which documents the presence of over 20 symptoms, then rates them by severity. Lower scores mean lesser severity.

duration of respiratory symptoms

时间窗: daily up to 14 days

Respiratory symptoms are measured daily; total number of days with symptoms will be calculated to produce a duration score

次要结局

  • sleep scores using the Franklin Health Sleep Scale(14 days)

研究者

发起方
Nutraceuticals Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Aromatherapy for Upper Respiratory Health | 临床试验